指南与共识神经技术与安全CTMR

血液或肿瘤疾病患者(包括细胞治疗)的中枢神经系统感染——德国血液学和肿瘤内科学会(DGHO)传染病工作组(AGIHO)指南2024年更新

CNS infections in patients with hematological or oncological diseases (including cellular therapies) - 2024 update of the guideline of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).
指南 / 共识 · Eur J Cancer · 2025-11-10

该指南更新了2016版血液或肿瘤疾病(HOD)患者中枢神经系统(CNS)感染管理指南,采用ESCMID标准进行推荐强度和证据级别分级,基于系统文献回顾和多学科专家共识,最终推荐于2024年9月获德国血液学和肿瘤内科学会传染病工作组批准。

要点

  • HOD患者CNS感染发生率高达15%,最常见的病原体为病毒或真菌。
  • 及时启动适当的诊断程序和抗感染治疗至关重要,治疗延迟会增加死亡率。
  • 指南提供基于证据的成人HOD患者CNS感染诊断和治疗建议。

核心结论

  • 基于证据的成人HOD患者CNS感染诊断和治疗建议对改善高发病率和高死亡率风险患者的预后至关重要。

研究设计与样本

  • 指南更新,基于系统文献回顾和阶梯式共识过程,涉及内科、血液学、肿瘤学、传染病学、神经病学、微生物学和放射学专家,推荐强度和证据级别按ESCMID标准分级,最终推荐于2024年9月获德国血液学和肿瘤内科学会传染病工作组批准。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Infections of the central nervous system (CNS) occur in up to 15 % of patients with hematological or oncological diseases (HOD), particularly in high-risk populations. The most common causative agents are viruses or fungi. Prompt initiation of adequate diagnostic procedures and anti-infective treatment is crucial, as treatment delays increase mortality.

METHODS: We present an update of our previous guideline published in 2016 on the management of CNS infections in patients with HOD. The grading of recommendation strength and level of evidence followed the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) standards, based on a systematic literature review and a stepwise consensus process involving experts in internal medicine, hematology, oncology, infectious diseases, neurology, microbiology, and radiology. This process included several web-based meetings by the guideline panel, whereas the final recommendations were approved by the assembly of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology in September 2024.

FINDINGS AND INTERPRETATION: Evidence-based recommendations on the diagnosis and treatment of CNS infections in adult patients with HOD are essential in daily clinical practice to improve outcomes for patients at high risk of morbidity and mortality.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Akdas R, Schalk E, Stemler J, et al. CNS infections in patients with hematological or oncological diseases (including cellular therapies) - 2024 update of the guideline of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Eur J Cancer. 2025. PMID: 41344068. doi:10.1016/j.ejca.2025.116103

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。